Author:
Onoue Satomi,Matsui Takuya,Kuriyama Kazuki,Ogawa Kumiko,Kojo Yoshiki,Mizumoto Takahiro,Karaki Shin-ichiro,Kuwahara Atsukazu,Yamada Shizuo
Funder
Ministry of Education, Culture, Sports, Science and Technology
Project of Shizuoka Prefecture and Shizuoka City Collaboration of Regional Entities for the Advancement of Technological Excellence, Japan Science and Technology Agency (JST)
Subject
Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry
Reference32 articles.
1. Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP;Abad;Curr Top Med Chem,2006
2. Inhalative nanomedicine—opportunities and challenges;Bur;Inhal Toxicol,2009
3. Inhalation drug delivery devices and emerging technologies;Chan;Expert Opin Ther Patents,2003
4. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease;Delgado;Nat Med,2001
5. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation;Delgado;J Immunol,1999
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献